Vaginal estrogen therapy and overactive bladder symptoms in postmenopausal patients after a tension-free vaginal tape procedure: a randomized clinical trial
Authors:
- Marzio Angelo ZulloMZMarzio Angelo Zullo
- Francesco PlottiFPFrancesco Plotti
- Marco CalcagnoMCMarco Calcagno
- Innocenza PalaiaIPInnocenza Palaia
- Ludovico MuziiLMLudovico Muzii
- Natalina ManciNMNatalina Manci
- Roberto AngioliRARoberto Angioli
- Pierluigi Benedetti PaniciPPPierluigi Benedetti Panici
- 1 July 2005
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Menopause
- Vol. 12 (4) , 421-427
Abstract
To evaluate whether the frequency of overactive bladder (OAB) symptoms increases in menopause patients after a tension-free vaginal tape (TVT) procedure, and to determine if topical estrogen therapy can help prevent these symptoms. After undergoing a preoperative assessment, enrolled patients were randomly allocated to receive TVT plus postoperative vaginal estrogen therapy (ET group) or TVT without adjunctive medical treatment (No ET group). The pre- and postoperative assessments included: acquisition of a urogynecologic history with standardized questions regarding urinary function (including a 10-grade visual analogue scale score), urogynecologic clinical examination, and urodynamic assessment. Follow-up assessments were performed at 1, 3, and 6 months after surgery. Fifty-six of 59 patients were evaluable; 28 received topic vaginal estrogen after surgery (ET group) and 28 did not receive adjunctive medical treatment (No ET group). The overall OAB syndrome rate in menopause patients (No ET group) was 7% (2 of 28 patients) at baseline and 32% (9 of 28 patients) 6 months after surgery (P = 0.04). At the 6-month follow-up assessment, the incidence of urinary urgency was 4% (1 of 28 patients) and 29% (8 of 28 patients) in the ET and No ET groups, respectively (P = 0.01). Differences in frequency and nocturia were not statistically significant. Analysis of the visual analogue scale scores revealed that at the 6-month follow-up assessment, urgency significantly improved in the ET group compared with the No ET group (0.23 +/- 1.0 vs 2.30 +/- 3.7, respectively; P = 0.02). The TVT procedure seems to increase the frequency of OAB syndrome in menopause patients. Vaginal estriol therapy significantly reduces symptoms of urinary urgency, has a high rate of patient satisfaction, and can be used to treat postmenopausal women for at least 6 months after a TVT procedure.Keywords
This publication has 33 references indexed in Scilit:
- Management of Overactive BladderNew England Journal of Medicine, 2004
- The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinenceBJOG: An International Journal of Obstetrics & Gynaecology, 2002
- Objective and subjective cure rates after tension-free vaginal tape for treatment of urinary incontinenceUrology, 2001
- The tension‐free vaginal tape procedure is successful in the majority of women with indications for surgical treatment of urinary stress incontinenceBJOG: An International Journal of Obstetrics & Gynaecology, 2001
- A Three-Year Postoperative Evaluation of Tension-Free Vaginal TapeGynecologic and Obstetric Investigation, 1999
- Efficacy of estrogen supplementation in the treatment of urinary incontinenceObstetrics & Gynecology, 1996
- An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinenceInternational Urogynecology Journal, 1996
- Burch colposuspension: a 10–20 year follow upBJOG: An International Journal of Obstetrics & Gynaecology, 1995
- Estrogen receptors in the human female lower urinary tractAmerican Journal of Obstetrics and Gynecology, 1981
- Genesis of the Vaginal Profile: A Correlated Classification of Vaginal RelaxationClinical Obstetrics & Gynecology, 1972